| Wolverhampton Company, MDTi, shows that innovation, investmenet and improvement brings rewards |
|
|
|
|
"We knew that MDTi could deliver this and the NHS shared my confidence, so I am so proud to see what the Company has already delivered. Most importantly, MDTi have already ensured that clinician's innovations have been delivered into the healthcare market, providing improved care in a cost effective manner, whilst also generating a financial return for both the clinicians and their organisations." Martin added: “When MDTi was first formed, my fellow directors and I drew up a five year plan to bring twenty products to the market by the end of 2010, and we are well on target to achieve this thanks to the fantastic support we have received. Within this support, which includes my colleagues, the inventors, the NHS and the manufacturers we use, I include my business bank manager Laura Plaza from the Royal Bank of Scotland. Although there has been so much negative press recently about Banks in general, my fellow directors and I have nothing but praise for Laura and RBS. We needed a bank who were willing to support a new company and that is exactly what they did." Royal Bank of Scotland Business Manager, Laura Plaza, said: "MDTi Limited is a real Wolverhampton success story, turning great ideas into essential medical devices for the benefit of patients worldwide. It is very exciting in the current economic climate to see a Company doing so well and to know the Royal Bank of Scotland has played a part. Solid support and guidance from dedicated relationship managers is key for any business and to prosper it is essential that business ventures like MDTi Limited take advantage of all the help they can get. I'm delighted we have been able to support the Company and wish everyone involved with MDTi be they the Directors, inventors, clinicians or manufacturers, continued success." Earlier this year, NatWest and RBS announced they have made an additional £250 million funding available to SMEs in the West Midlands. This further commitment to the SME sector is in addition to providing traditional debt finance, offering businesses the opportunity to access other avenues available to help them manage their capital and cash flow through the current economic downturn. View or Download the full press release in PDF format. |




Martin Levermore, Chief Executive Officer of MDTi, said: "When I and my fellow directors came up with the idea of the company, we had a very strong ethical drive, whilst not losing the important balance with being commercial, and was fed up with having to look abroad for products which we knew started their lives as ideas by U.K. based clinicians. We were acutely aware that no other company in the country were working with the NHS to capture the ideas coming from their people under a single brand and hence these innovations were taking a lifetime to come to market to help patients.